scispace - formally typeset
C

Christina S. Kong

Researcher at Stanford University

Publications -  133
Citations -  8098

Christina S. Kong is an academic researcher from Stanford University. The author has contributed to research in topics: Cancer & Head and neck squamous-cell carcinoma. The author has an hindex of 36, co-authored 123 publications receiving 6535 citations. Previous affiliations of Christina S. Kong include University of California, San Francisco.

Papers
More filters
Journal ArticleDOI

Lysyl oxidase is essential for hypoxia-induced metastasis

TL;DR: It is shown that LOX expression is regulated by hypoxia-inducible factor (HIF) and is associated with Hypoxia in human breast and head and neck tumours, and is a good therapeutic target for preventing and treating metastases.
Journal ArticleDOI

The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society

TL;DR: A multidisciplinary panel comprised principally of radiologists and pulmonologists from 10 countries with experience managing COVID-19 patients across a spectrum of healthcare environments evaluated the utility of imaging within three scenarios representing varying risk factors, community conditions, and resource constraints, resulting in five main and three additional recommendations intended to guide medical practitioners in the use of CXR and CT in the management of COIDs.
Journal ArticleDOI

Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer

TL;DR: It is shown that Notch signalling can be both tumour suppressive and pro-tumorigenic in small-cell lung cancer, and the presence of these cells may serve as a biomarker for the use of Notch pathway inhibitors in combination with chemotherapy in select patients with small- cell lung cancer.
Journal ArticleDOI

Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility

TL;DR: The identification of widespread chromatin changes during SCLC progression reveals an unexpected global reprogramming during metastatic progression, and indicates that Nfib is necessary and sufficient to increase chromatin accessibility at a large subset of the intergenic regions.